NDM-1: The superbug?;NDM-1: Il superbug?

Infezioni in Medicina

Volumn 19, Issue 4, 2011, Pages 224-234

  Pittalis, Silvia ^a   Ferraro, Federica ^a   Puro, Vincenzo ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Antibiotic resistance; Carbapenemase resistance; New Delhi Metallo lactamase 1

Indexed keywords

METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; REVIEW;

ABSCESS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BUTTOCKS; COLISTIN; DIABETES COMPLICATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INDIA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SWEDEN; TRAVEL; TREATMENT OUTCOME;

EID: 84856617391     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents. Chemother. 53, 5046-5054, 2009.
2. Health Protection Agency. Multi-resistant hospital bacteria linked to India or Pakistan. Health Protection Report 3, 3-4, 2009. http://www.hpa.org.uk/ hpr/archives/2009/hpr2609.pdf.
3. Centers for Disease Control and Prevention. Detection of Enterobacteriaceae isolates carrying metallo-β-lactamase-United States, 2010. MMWR 59, 750, 2010.
4. Kumarasamy K.K., Toleman M.A., Walsh T.R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597-602, 2010.
5. Blaskar E. New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 749, 2010.
6. Indian Network for Surveillance of Antimicrobial Resistance Group. New Delhi metallo-β-latcamase 1. Lancet Infect. Dis. 10, 749-750, 2010.
7. Sirohi B. New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 750, 2010.
8. Tempe D.K. New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 750-751, 2010.
9. Gibb A.P., McCallum A.K. New Delhi metallo-β-latcamase 1. Lancet Infect. Dis. 10, 751-752, 2010.
10. Kant S., Haldar P. Is NDM-1 actually being imported to UK from India? Indian J. Public Health 54,151-154, 2010.
11. Linking India to superbug unfair and wrong, says India. Hindustan Times. Aug 12, 2010. http://www.hindustantimes.com/Linking-Indiatosuperbug-unfair-and-wrong-says-India/Article1-585840.aspx.
12. Goel N., Wattal C. New Delhi metallo-β-latcamase 1. Lancet Infect. Dis. 10, 751, 2010.
13. Walsh T.R. Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents S3, 8-14, 2010.
14. Raghunath D. New metallo [-lattamasi. Indian J. Med. Res. 132, 478-481, 2010.
15. Castanheira M., Deshpande L.M., Mathai D., Bell J.M., Jones R.N., Mendes R.E. Early dissemination of NDM-1-and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program (2006-2007). Antimicrob. Agents Chemother. 55, 1274-1282, 2011.
16. Deshpande P., Rodriguez C., Shetty A., Kapadia F., Hedge A., Soman R. New Delhi metallo-β-lactamase (NDM-1) in Enterobacteriaceae: treatment op-tions with carbapenems compromised. J. Assoc. Physicians India 58, 147-149, 2010.
17. Cohen Stuart J.W., Voets G., Versteeg D., et al. The first carbapenemase-producing Klebsiella pneumonia strains in the Netherlands are associated with international travel. In Abstracts of the Twenty European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 2010, Abstract P1284.
18. Institut Scientifique de la Santé Publique. Guidelines for control of infections in case of cross-border transfer of patients hospitalized in countries with high endemicity of carbapenenemase-producing Enterobacteriaceae (Sept 23, 2010). http://www.nsih.be/download/MDR/NewDelhi_ fiche_alert_V5_FR.pdf
19. Hammerum A.M., Toleman M.A., Hansen F., et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 829-830, 2010.
20. Samuelsen Ø., Thilesen C.M., Heggelund L., Vada A.N., Kümmel A., Sundsfjord A. Identification of NDM-1 producing Enterobacteriaceae in Norway. J. Antimicrob. Chemother. 66, 3, 670-672, 2011.
21. Göttig S., Pfeifer Y., Wichelhaus T.A., et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 828-829, 2010.
22. Leverstein-van Hall M.A., Cohen Stuart J., Voets G.M., Versteeg D., Tersmette T., Fluit A.C. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 830-831, 2010.
23. Pfeifer Y., Witte W., Holfelder M., Busch J., Nordmann P., Poirel L. NDM-1-producing Escherichia coli in Germany. Antimicrob. Agents Chemother. 55, 1318-1319, 2011.
24. Struelens M.J., Monnet D.L., Magiorakos A., Santos O'Connor F., Giesecke J., the European NDM-1 Survey Participants. New Delhi metallo-β-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro. Surveill. 15, 46, pii: 19716, 2010.
25. Poirel L., Hombrouk-Alet C., Freneaux C., Bernabeu S., Nordmann P. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 832, 2010.
26. Poirel L., Ros A., Carricajo A., et al. Extremely Drug-Resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob. Agents Chemother. 55, 447-448, 2011.
27. Poirel L., Fortineau N., Nordmann P. International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob. Agents Chemother. 55, 4, 1821-1822, 2011.
28. Poirel L., Al Maskari Z., Al Rashdi F., Bernabeu S., Nordmann P. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J. Antimicrob. Chemother. 66, 304-306, 2011.
29. Poirel L., Revathi G., Bernabeu S., Nordmann P. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob. Agents Chemother. 55, 934-936, 2011.
30. Webster P.C. Global action urged in response to new breed of drug-resistant bacteria. CMAJ 182, 1602-1603, 2010.
31. Mulvey M.R., Grant J.M., Plewes K., Roscoe D., Boyd D.A. New Delhi metallo-β-lactamase in Klebsiella pnemoniae and Escherichia coli, Canada. Emerg. Infect. Dis. 17, 103-106, 2011.
32. Peirano G., Ahmed-Bentley J., Woodford N, Pitout J.D. New Delhi Metallo-P-lactamase from traveller returning to Canada. Emerg. Infect. Dis. 17, 242-244, 2011.
33. Pillai D.R., McGeer A., Low D.E. New Delhi metallo-β-lactamase-1 in Enterobacteriaceae: emerging resistance. CMAJ 183, 59-64, 2011.
34. NDM-1 in Taiwan. J. Clin. Med. Assoc. 73, 596-598, 2010.
35. Koh T.H., Khoo C.T., Wijaya L., et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 828, 2010.
36. Fernando G.A.T.P., Collignon P.J., Bell J.M. A risk for returned travellers: the "post-antibiotic era". Med. J. Aust. 193, 59, 2010.
37. Poirel L., Lagrutta E., Tayor P., Pham J., Nordmann P. Emergence of metallo-β-lactamase NDM-1 producing multidrug-resistant Escherichia coli in Australia. Antimicrob. Agents Chemother. 54, 4914-4916, 2010.
38. Sidjabat H., Nimmo G.R., Walsh T.R., et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-β-lactamase. Clin. Inf. Dis. 52, 481-484, 2011.
39. Bogaerts P., Verroken A., Jans B., Denis O., Glupczynski Y. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10, 831-832, 2010.
40. NDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65, 2253-2254, 2010.
41. Basu S., Singh A.K., Nair G.B. Emerging carbapenem resistance in the context of a New metallo-β-lactamase (NDM-1). Natl. Med. J. India 23, 261-262, 2010.
42. Zarfel G., Hoenigl M., Leitner E., et al. Emergence of New Delhi metallo-β-lactamase, Austria. Emerg. Inf. Dis. 17, 129-130, 2011.
43. Moellering R.C. Jr. NDM-1-A cause for worldwide concern. N. Engl. J. Med. 363, 2377-2379, 2010.
44. Health Protection Agency. Advice on carbapenemase producers: recognition, infection control and treatment. 2011. http://www.hpa.org.uk/web/ HPAwebFile/HPAweb_C/1294740725984.
45. European Centre for Disease Prevention and Control Antimicrobial Resistance and Healthcare-Associated Infections Programme. Antimicrobial resistance 2010: global attention on carbapenemaseproducing bacteria. Euro. Surveill. 15, 46, pii: 19719, 2010.
46. Special Eurobarometer 338. Antimicrobial resistance, November-December 2009. Brussels, TNS Opinion & Social 2010. http://ec.europa.eu/health/antimicrobial_resistance/ eurobarometers/index_en.htm.
47. Finch R. Generic antibiotics, antibiotic resistance, and drug licensing. Lancet Inf. Dis. 10: 754, 2010.
48. World Health Organization. Antimicrobial resistance. Revisiting the "tragedy of the commons". Bull. World Health Organ. 88, 805-806, 2010.
49. Grundmann H., Livermore D.M., Giske C.G., and the CNSE Working Group. Carbapenem-nonsusceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro. Surveill. 15, 46, pii: 19711, 2010.
50. Rolain J.M., Parola P., Cornaglia G. New Delhi metallo-β-lactamase (NDM-1): toward a new pandemia? Clin. Microbiol. Inf. 16, 1699-1701, 2010.
51. de Costa A., Mavalankar D. New Delhi metallo-β-latcamase 1. Lancet Infect. Dis. 10, 752, 2010.
52. Walsh T.R., Toleman M.A., Sarma J.B., Irfan S., Woodford N., Livermore D.M. New Delhi metallo-β-latcamase 1. Lancet Infect. Dis. 10, 752-754, 2010.
53. Nordmann P., Poirel L., Carrr A., Toleman M.A., Walsh T.R. How to detect NDM-1 producers? J. Clin. Microbiol. 49, 718-721 2011.
54. Livermore D.M. The need for new antibiotics. Clin. Microbiol. Infect. 10, S4:1-9, 2004.
55. Boucher H.W., Talbot G.H., Bradley J.S., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Inf. Dis. 48, 1-12, 2009.
56. European Centre for Disease Prevention and Control/European Medicines Agency. The bacterial challenge: time to react. http://www.ema.europa.eu/docs/en_GB/document_ library/Report/2009/11/WC500008770.pdf
57. Urgently needed: new antibiotics. Lancet 374, 1868, 2009.
58. Bush K. Alarming [-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Current Opinion Microbiol. 13, 558-564, 2010.
59. Vento S., Cainelli F. The need for new antibiotics. Lancet 375, 637, 2010.
60. Bonomo R.A. New Delhi Metallo-[-lactamase and multidrug resistance: a global SOS? Clin. Inf. Dis. 52, 485-487, 2011.
61. Arya S.C., Agarwal N. Response to New Delhi metallo-β-lactamase (NDM-1): an emerging threat among Enterobacteriaceae. J. Formos. Med. Assoc. 109, 921-922, 2010.
62. Centers for Disease Control and Prevention. Guidance for control of infections with carbapenemresistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR 58, 256-260, 2009.
63. Società Italiana Multidisciplinare per la Prevenzione delle Infezioni nelle Organizzazioni Sanitarie. I batteri Gram negativi multiresistenti: un problema emergente e di attualità. Indicazioni gestionali. http://www.simpios.org/ufiles/File/Documento% 20E-MDR%2009272010.pdf.
64. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement (June 2010 update). M100-S20-U, 30(15), 2010. http:// www.clsi.org/source/orders/free/m100-s20-u.pdf.
65. European Committee on Antimicrobial Susceptibility Testing. Imipenem. Rationale for the EUCAST clinical breakpoints, version 1.3. 1 Jun 2009. http://www.eucast.org/fileadmin/src/media/PDF s/EUCAST_files/Rationale_documents/Imipenem_ EUCAST_Rationale_Document_1.3_090601.pdf.
66. European Committee on Antimicrobial Susceptibility Testing. EUCAST Clinical Breakpoint Table v. 1.1 2010-04-27, Enterobacteriaceae. http://eucast.org./fileadmin/src/media/PDFs/EU CAST_files/Disk_test_documents/EUCAST_breakpoints_ v1.1.xls.
67. World Health Organization. World Health Day-7 April 2011. Antimicrobial resistance and its global spread. http://www.who.int/world-healthday/ en/.